SlideShare a Scribd company logo
1 of 5
Download to read offline
Abstract:
Schistosomiasis is a water-born parasitic disease in humans caused by various species of
trematods of the genus Schistosoma. The effect of the infection causes impaired growth and
cognitive development in children; and in adults, hyper tension of abdominal blood pressure,
hepatospleenomegali, bladder cancer and kidney failure as a result of chronic infection. It is the
second most devastating parasitic disease in tropical and sub-tropical areas after malaria. More
than 200 million people worldwide have been infecting by the parasite. It is considered as a
neglected tropical disease (Hotez, 2007). Poor socioeconomic conditions are mainly responsible
for the transmission of the disease, the rate of which is increasing worldwide.
Transmission of the disease mainly occurs by cercariae which is a larvae form of parasite
Schistosoma. The parasite performs a complex life cycle where snail is intermediate host and
human is main host. The intermediate host- snail, releases the cercariae into fresh-water. Human
skin in contact with the contaminated fresh water results in penetration of the cercariae through
skin and transforms into larva which then migrates to the hepatic portal system as a part of its life
cycle. Control of the disease transmission mainly depends on the improvement in sanitation,
health education, snail control as well as chemotherapy. As there are no vaccines for the parasitic
disease reported untill now, chemotherapy is the best way to control the disease. The currently
available chemotherapeutic drugs for schistosomiasis are praziquantel (PZQ), Artemether, 2-
(alkylamino)-1-phenyl-1-ethanethiosulfuric acids, all of which are now limited in application.
PZQ is the most effective drug to the present time against all types of schistosomiasis and
considerably less side effects. As the drug target voltage-gated Ca2+ channels of pathogen, it is
able to induce contraction and therby paralyses but only in adult pathogens and it is believed I
has no effect on immature schistosomes. The efficacy of PZQ not only depends on the different
developmental stage of infection, but also on host’s immune system. As the paralyzed
schistosome is destroyed by phagosistosis of the immune system, the efficacy of PZQ needs
strong host immune system. Even though PZQ is effective for almost all types of
schistosomiasis, the drug alone has partial-protective activity. However the activity of the drug
become reduces due to the generation of resistant pathogen (Fallon, P.G. 1994). In the case of
other available drugs, Oxamniquine is mainly effective to treat intestinal schistosomiasis in
Africa and South America, whereas Metrifonate has been using to treat urinary schistosomiasis
worldwide, artemisisnin is significantly less effective against adult schistosome parasites. Due to
lake of proper treatment and preventive therapy the rate of the disease occurrence is increasing
rapidly worldwide and will become a remarkable threat to human populations in the near future.
The eradication of the disease is completely impossible, as there are no vaccine for the parasitic
disease has reported untill now. Under the present circumstances, a safe, non-toxic but effective
drug should be urgently introduced to control the schistosomiasis in novel way by targeting
common biochemical mechanism. Thioredoxin glutathione reductase (TGR) is one of such
common pathway which present in all developmental stages as well as in all infectious pathogen.
By quantitative high-throughput screen (qHTS) of NIH Molecular Libraries, followed by
confirmatory and target deconvolution assay, four promising series were identified (1. oxadiazole
2-oxides, 2. phosphinic amides, 3. quinolinyl sulfonamides , 4. Phosphoramidite) as Thioredoxin
glutathione reductase (TGR) inhibitors. The aim of this study was to analyse the activity
phosphinic amides and oxadiazole 2-oxides against antioxidant pathway at all developmental
stages of parasite as well as all major species infecting humans, and S. mansoni–infected mice.
Among the ten selected compound, 4-phenyl-1,2,5-oxadiazole-3-carbonitrile-2-oxide showed
most active against in-vitro adult pathogen as well as multiple parasitic stages and egg-
associated pathologies by generating NO. The protective activity of the compound was also
observed against the three major species of schistosome pathogen infecting human. The
cytotoxic effect of the compound was lower as compared to the PZQ.
Discussion:
The level of activity of compound 9 was equal to or better than that of the currently used drug, PZQ, and surpasses
all landmarks for new lead compounds for schistosomiasis control. The low cytotoxicity and high bioactivity and
tolerance by mice of compound 9 support the potential of this compound as a highly effective lead compound for
human schistosomiasis.
in the series of oxadiazole 2-oxides, 4-phenyl-1,2,5-oxadiazole-3-carbonitrile-2-oxide is
identified as the most active compound which showed a significant activity against almost all
stages of the parasite life cycle. Therefore it might be a effective drug to treat both short-term
and long-term schistosomiasis. Thus, the compound might be potential new drug which able to
treat schistosomiasis more effectively at any point during the infection. Unlike PZQ, the
compound able to reduce the larval count in lung, it might be a promising prophylactic drug for
schistosomiasis treatment. PZQ is much less effective against juvenile liver parasites than against adult
parasites, producing only a 25–30% reduction in worm burdens. Although artemether affords B80% reduction if
juvenile parasites are targeted, it is less effective against adult schistosome parasites, resulting in o50% reduction in
worm burden 31. In addition, compound 9 was found to be active against adults…..
compound 9 was found to be active against adults of the other main schistosome species infecting humans, S.
japonicum and S. haematobium. Therefore, compound 9, or its derivatives, could be useful……
The almost completely dependence on PZQ for schistosomiasis treatment lead to the increase of
developing resistant strains worldwide resulting in out-of-control of the disease effect. A the
compound have different mode of action than PZQ to kill the pathogen, might be a potential drug
to treat PZQ-resistant strain. Apart from this, the compound might be a perfect choice for
combination therapy with PZQ or artemisnin to treat more effectively than alone.
Future scope:
The analysis is undoubtedly a prominence step forward, but the goal of new schistomatosis drug
development is far from the point of view. Rather, it envisages an initiative point to develop new
safe but potential drug to control the divesting effect of sichtomatosis worldwide. Although the
study conclude that the compound has a less cytotoxic effect with better tolerance by mouse in
comparison to currently used drug PZQ, further study needs to confirm the protective activity
against all developmental stage of the compound is more than the currently used drug, PZQ.
Next goal would be to measure the efficiency of the compound against all developmental stage
in a single in vivo experiment by using PZQ as a positive control.
The compound act as TGR inhibitor lead to impairment of redox mechanism in pathogen,
ultimately kill it. Like PZQ, the killed pathogen in host tissue may be target by the host’s
immune system to eliminate by phagosytosis. Thus the efficacy of the drug might also be
depending on the host immunity; consequently sex, race or others. However the effect of the
compound on the host’s cell-enzyme: Thioredoxin Reductase (TrxR), Glutaredoxin (Grx) and
Glutathione Reductase (GR) also needs to analyze. By using various derivatives of the
compound, the efficacy of the drug might possible to increase selectively. As the compound
generates toxic NO, the side effects also need to analyze more details before using as drug.
It is important to conduct pharmacokinetic analysis of the compound for biological half life ,
excretion or elimination rate constant for the compound before going to clinical trial.
Ref:
1. Hotez, P.J. et al. Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018–1027
(2007).
2. Fallon, P.G. & Doenhoff, M.J. Drug-resistant schistosomiasis: resistance to praziquantel
and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop.
Med. Hyg. 51, 83–88 (1994).
3. Herwaldt, B.L., Tao, L.F., van Pelt, W., Tsang, V.C. & Bruce, J.I. Persistence of
Schistosoma haematobium infection despite multiple courses of therapy with
praziquantel. Clin. Infect. Dis. 20, 309–315 (1995).
4. Murray-Smith, S.Q., Scott, B.J., Barton, D.P. & Weinstein, P. A case of refractory
schistosomiasis. Med. J. Aust. 165, 458 (1996).
5. Ismail, M. et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni
isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60, 932–935 (1999).
6. Simeonov, A. et al. Quantitative high-throughput screen identifies inhibitors of the
Schistosoma mansoni redox cascade. PLoS Negl. Trop. Dis 2, e127 (2008).
7.
Jounal clab 2

More Related Content

What's hot

Human genetic susceptibility to mycobacterium tuberculosis 1
Human genetic susceptibility to mycobacterium tuberculosis 1Human genetic susceptibility to mycobacterium tuberculosis 1
Human genetic susceptibility to mycobacterium tuberculosis 1Shweta Kaul
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadVaraprasad Padala
 
New agents for the treatment of drug resistant Mycobacterium Tuberculosis
New agents for the treatment of drug resistant Mycobacterium TuberculosisNew agents for the treatment of drug resistant Mycobacterium Tuberculosis
New agents for the treatment of drug resistant Mycobacterium TuberculosisAreej Abu Hanieh
 
The treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...
The  treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...The  treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...
The treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...Kishore Chinna
 
host genomics and tuberculosis
host genomics and tuberculosishost genomics and tuberculosis
host genomics and tuberculosisabdalla ibrahim
 
Invasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisInvasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisKhaled Taema
 
A novel coronavirus associated with severe acute respiratory syndrome
A novel coronavirus associated with severe acute respiratory syndromeA novel coronavirus associated with severe acute respiratory syndrome
A novel coronavirus associated with severe acute respiratory syndromeJuan Rubio
 
Dexamethasone, potential treatment on covid 19
Dexamethasone, potential treatment on covid 19Dexamethasone, potential treatment on covid 19
Dexamethasone, potential treatment on covid 19Veeprho Laboratories
 
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013Hivlife Info
 
Multi drug resistance (MDR TB) tuberculosis
Multi drug resistance (MDR TB) tuberculosis Multi drug resistance (MDR TB) tuberculosis
Multi drug resistance (MDR TB) tuberculosis Mohan Giri
 
5) anti microbial resistance
5) anti microbial resistance5) anti microbial resistance
5) anti microbial resistanceDipsikhaAryal
 
Deciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgsDeciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgsVictorAkinseyeOluwat
 
New approaches for medical management of Chronic Granulomatous Disease.
New approaches for medical management of Chronic Granulomatous Disease.New approaches for medical management of Chronic Granulomatous Disease.
New approaches for medical management of Chronic Granulomatous Disease.Dmitri Popov
 

What's hot (18)

MDR T.B.
MDR T.B.MDR T.B.
MDR T.B.
 
Human genetic susceptibility to mycobacterium tuberculosis 1
Human genetic susceptibility to mycobacterium tuberculosis 1Human genetic susceptibility to mycobacterium tuberculosis 1
Human genetic susceptibility to mycobacterium tuberculosis 1
 
FLUOROQUINOLONES
FLUOROQUINOLONESFLUOROQUINOLONES
FLUOROQUINOLONES
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasad
 
The world of coronaviruses
The world of coronavirusesThe world of coronaviruses
The world of coronaviruses
 
New agents for the treatment of drug resistant Mycobacterium Tuberculosis
New agents for the treatment of drug resistant Mycobacterium TuberculosisNew agents for the treatment of drug resistant Mycobacterium Tuberculosis
New agents for the treatment of drug resistant Mycobacterium Tuberculosis
 
Multi-drug resistant Tuberculosis
Multi-drug resistant TuberculosisMulti-drug resistant Tuberculosis
Multi-drug resistant Tuberculosis
 
The treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...
The  treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...The  treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...
The treatment of multi drug resistant tuberculosis (mdr-tb) with sirturo (be...
 
host genomics and tuberculosis
host genomics and tuberculosishost genomics and tuberculosis
host genomics and tuberculosis
 
Invasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsisInvasive candidiasis the hidden cause of sepsis
Invasive candidiasis the hidden cause of sepsis
 
A novel coronavirus associated with severe acute respiratory syndrome
A novel coronavirus associated with severe acute respiratory syndromeA novel coronavirus associated with severe acute respiratory syndrome
A novel coronavirus associated with severe acute respiratory syndrome
 
Dexamethasone, potential treatment on covid 19
Dexamethasone, potential treatment on covid 19Dexamethasone, potential treatment on covid 19
Dexamethasone, potential treatment on covid 19
 
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013
Recent Advances in Multidrug-Resistant TB of HIV/TB coinfection.2013
 
Multi drug resistance (MDR TB) tuberculosis
Multi drug resistance (MDR TB) tuberculosis Multi drug resistance (MDR TB) tuberculosis
Multi drug resistance (MDR TB) tuberculosis
 
5) anti microbial resistance
5) anti microbial resistance5) anti microbial resistance
5) anti microbial resistance
 
Deciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgsDeciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgs
 
New approaches for medical management of Chronic Granulomatous Disease.
New approaches for medical management of Chronic Granulomatous Disease.New approaches for medical management of Chronic Granulomatous Disease.
New approaches for medical management of Chronic Granulomatous Disease.
 
Hiv
HivHiv
Hiv
 

Viewers also liked

Invierno en Amsterdam 2012
Invierno en Amsterdam 2012Invierno en Amsterdam 2012
Invierno en Amsterdam 2012charliefc
 
Adbox Login 2013
Adbox Login 2013Adbox Login 2013
Adbox Login 2013AdboxLt
 
наша планета земля
наша планета землянаша планета земля
наша планета земляandreylishuk
 
Professionalnoe samosoznanie uchitelya
Professionalnoe samosoznanie uchitelyaProfessionalnoe samosoznanie uchitelya
Professionalnoe samosoznanie uchitelyaOlga2295
 
наша планета земля
наша планета землянаша планета земля
наша планета земляandreylishuk
 
Pandangan Iman Kristen Terhadap Dugem dan Diskotik
Pandangan Iman Kristen Terhadap Dugem dan DiskotikPandangan Iman Kristen Terhadap Dugem dan Diskotik
Pandangan Iman Kristen Terhadap Dugem dan DiskotikHanson Siagian
 
Pestisida Alami dan Cara Pembuatannya
Pestisida Alami dan Cara Pembuatannya Pestisida Alami dan Cara Pembuatannya
Pestisida Alami dan Cara Pembuatannya Hanson Siagian
 
Upaya penegakan hak asasi manusia di indonesia
Upaya penegakan hak asasi manusia di indonesiaUpaya penegakan hak asasi manusia di indonesia
Upaya penegakan hak asasi manusia di indonesiaHanson Siagian
 
Teorias de Crecimiento Craneofacial
Teorias de Crecimiento CraneofacialTeorias de Crecimiento Craneofacial
Teorias de Crecimiento CraneofacialMarceUAM
 

Viewers also liked (10)

New Resume......
New Resume......New Resume......
New Resume......
 
Invierno en Amsterdam 2012
Invierno en Amsterdam 2012Invierno en Amsterdam 2012
Invierno en Amsterdam 2012
 
Adbox Login 2013
Adbox Login 2013Adbox Login 2013
Adbox Login 2013
 
наша планета земля
наша планета землянаша планета земля
наша планета земля
 
Professionalnoe samosoznanie uchitelya
Professionalnoe samosoznanie uchitelyaProfessionalnoe samosoznanie uchitelya
Professionalnoe samosoznanie uchitelya
 
наша планета земля
наша планета землянаша планета земля
наша планета земля
 
Pandangan Iman Kristen Terhadap Dugem dan Diskotik
Pandangan Iman Kristen Terhadap Dugem dan DiskotikPandangan Iman Kristen Terhadap Dugem dan Diskotik
Pandangan Iman Kristen Terhadap Dugem dan Diskotik
 
Pestisida Alami dan Cara Pembuatannya
Pestisida Alami dan Cara Pembuatannya Pestisida Alami dan Cara Pembuatannya
Pestisida Alami dan Cara Pembuatannya
 
Upaya penegakan hak asasi manusia di indonesia
Upaya penegakan hak asasi manusia di indonesiaUpaya penegakan hak asasi manusia di indonesia
Upaya penegakan hak asasi manusia di indonesia
 
Teorias de Crecimiento Craneofacial
Teorias de Crecimiento CraneofacialTeorias de Crecimiento Craneofacial
Teorias de Crecimiento Craneofacial
 

Similar to Jounal clab 2

Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...
Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...
Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...Mohammad Aziz
 
Aziz & abdelaziz 2016
Aziz & abdelaziz 2016Aziz & abdelaziz 2016
Aziz & abdelaziz 2016Mohammad Aziz
 
Dangers Of Cystic Fibrosis Foundation
Dangers Of Cystic Fibrosis FoundationDangers Of Cystic Fibrosis Foundation
Dangers Of Cystic Fibrosis FoundationBeth Salazar
 
Carolina_Pohl_Intl_Innovation_171_Research_Media
Carolina_Pohl_Intl_Innovation_171_Research_MediaCarolina_Pohl_Intl_Innovation_171_Research_Media
Carolina_Pohl_Intl_Innovation_171_Research_MediaCarlien Pohl
 
Review about toxoplasma
Review about  toxoplasmaReview about  toxoplasma
Review about toxoplasmaFatrin Ķľ
 
WGHA Discovery Series: Robert Sinden
WGHA Discovery Series: Robert SindenWGHA Discovery Series: Robert Sinden
WGHA Discovery Series: Robert SindenUWGlobalHealth
 
The Role Of Superficial Yeast Infections In Humans
The Role Of Superficial Yeast Infections In HumansThe Role Of Superficial Yeast Infections In Humans
The Role Of Superficial Yeast Infections In HumansHeidi Owens
 
Ratycz ADT Fellowship 2015
Ratycz ADT Fellowship 2015Ratycz ADT Fellowship 2015
Ratycz ADT Fellowship 2015Connor Ratycz
 
What Is The Characteristics Of Gram Positive Or Gram...
What Is The Characteristics Of Gram Positive Or Gram...What Is The Characteristics Of Gram Positive Or Gram...
What Is The Characteristics Of Gram Positive Or Gram...Katie Williams
 
Healthcare-Associated Pneumonia Case Study Essay
Healthcare-Associated Pneumonia Case Study EssayHealthcare-Associated Pneumonia Case Study Essay
Healthcare-Associated Pneumonia Case Study EssayJen Cloud
 
Anti fungal therapies
Anti fungal therapiesAnti fungal therapies
Anti fungal therapiesPari Doll
 
Cell Proliferation And The Control Of Cellular Function
Cell Proliferation And The Control Of Cellular FunctionCell Proliferation And The Control Of Cellular Function
Cell Proliferation And The Control Of Cellular FunctionAlison Hall
 
Gram-positive Toxic Shock Syndromes
Gram-positive Toxic Shock SyndromesGram-positive Toxic Shock Syndromes
Gram-positive Toxic Shock Syndromesmeducationdotnet
 
Bio da 9 (ppt)
Bio da 9 (ppt)Bio da 9 (ppt)
Bio da 9 (ppt)JamesSabu
 
The role of natural products in regulating pyroptosis
The role of natural products in regulating pyroptosisThe role of natural products in regulating pyroptosis
The role of natural products in regulating pyroptosisLucyPi1
 

Similar to Jounal clab 2 (20)

Anti-protozoal.pptx
Anti-protozoal.pptxAnti-protozoal.pptx
Anti-protozoal.pptx
 
Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...
Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...
Biochemical studies on the effects of Commiphora molmol extract (Mirazid) com...
 
Aziz & abdelaziz 2016
Aziz & abdelaziz 2016Aziz & abdelaziz 2016
Aziz & abdelaziz 2016
 
Malaria vaccine
Malaria vaccineMalaria vaccine
Malaria vaccine
 
CYP51
CYP51CYP51
CYP51
 
Dangers Of Cystic Fibrosis Foundation
Dangers Of Cystic Fibrosis FoundationDangers Of Cystic Fibrosis Foundation
Dangers Of Cystic Fibrosis Foundation
 
Carolina_Pohl_Intl_Innovation_171_Research_Media
Carolina_Pohl_Intl_Innovation_171_Research_MediaCarolina_Pohl_Intl_Innovation_171_Research_Media
Carolina_Pohl_Intl_Innovation_171_Research_Media
 
Review about toxoplasma
Review about  toxoplasmaReview about  toxoplasma
Review about toxoplasma
 
shuminasa
shuminasashuminasa
shuminasa
 
WGHA Discovery Series: Robert Sinden
WGHA Discovery Series: Robert SindenWGHA Discovery Series: Robert Sinden
WGHA Discovery Series: Robert Sinden
 
The Role Of Superficial Yeast Infections In Humans
The Role Of Superficial Yeast Infections In HumansThe Role Of Superficial Yeast Infections In Humans
The Role Of Superficial Yeast Infections In Humans
 
Ratycz ADT Fellowship 2015
Ratycz ADT Fellowship 2015Ratycz ADT Fellowship 2015
Ratycz ADT Fellowship 2015
 
What Is The Characteristics Of Gram Positive Or Gram...
What Is The Characteristics Of Gram Positive Or Gram...What Is The Characteristics Of Gram Positive Or Gram...
What Is The Characteristics Of Gram Positive Or Gram...
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Healthcare-Associated Pneumonia Case Study Essay
Healthcare-Associated Pneumonia Case Study EssayHealthcare-Associated Pneumonia Case Study Essay
Healthcare-Associated Pneumonia Case Study Essay
 
Anti fungal therapies
Anti fungal therapiesAnti fungal therapies
Anti fungal therapies
 
Cell Proliferation And The Control Of Cellular Function
Cell Proliferation And The Control Of Cellular FunctionCell Proliferation And The Control Of Cellular Function
Cell Proliferation And The Control Of Cellular Function
 
Gram-positive Toxic Shock Syndromes
Gram-positive Toxic Shock SyndromesGram-positive Toxic Shock Syndromes
Gram-positive Toxic Shock Syndromes
 
Bio da 9 (ppt)
Bio da 9 (ppt)Bio da 9 (ppt)
Bio da 9 (ppt)
 
The role of natural products in regulating pyroptosis
The role of natural products in regulating pyroptosisThe role of natural products in regulating pyroptosis
The role of natural products in regulating pyroptosis
 

Recently uploaded

ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 

Recently uploaded (20)

ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 

Jounal clab 2

  • 1. Abstract: Schistosomiasis is a water-born parasitic disease in humans caused by various species of trematods of the genus Schistosoma. The effect of the infection causes impaired growth and cognitive development in children; and in adults, hyper tension of abdominal blood pressure, hepatospleenomegali, bladder cancer and kidney failure as a result of chronic infection. It is the second most devastating parasitic disease in tropical and sub-tropical areas after malaria. More than 200 million people worldwide have been infecting by the parasite. It is considered as a neglected tropical disease (Hotez, 2007). Poor socioeconomic conditions are mainly responsible for the transmission of the disease, the rate of which is increasing worldwide. Transmission of the disease mainly occurs by cercariae which is a larvae form of parasite Schistosoma. The parasite performs a complex life cycle where snail is intermediate host and human is main host. The intermediate host- snail, releases the cercariae into fresh-water. Human skin in contact with the contaminated fresh water results in penetration of the cercariae through skin and transforms into larva which then migrates to the hepatic portal system as a part of its life cycle. Control of the disease transmission mainly depends on the improvement in sanitation, health education, snail control as well as chemotherapy. As there are no vaccines for the parasitic disease reported untill now, chemotherapy is the best way to control the disease. The currently available chemotherapeutic drugs for schistosomiasis are praziquantel (PZQ), Artemether, 2- (alkylamino)-1-phenyl-1-ethanethiosulfuric acids, all of which are now limited in application. PZQ is the most effective drug to the present time against all types of schistosomiasis and considerably less side effects. As the drug target voltage-gated Ca2+ channels of pathogen, it is able to induce contraction and therby paralyses but only in adult pathogens and it is believed I has no effect on immature schistosomes. The efficacy of PZQ not only depends on the different developmental stage of infection, but also on host’s immune system. As the paralyzed schistosome is destroyed by phagosistosis of the immune system, the efficacy of PZQ needs strong host immune system. Even though PZQ is effective for almost all types of schistosomiasis, the drug alone has partial-protective activity. However the activity of the drug become reduces due to the generation of resistant pathogen (Fallon, P.G. 1994). In the case of other available drugs, Oxamniquine is mainly effective to treat intestinal schistosomiasis in Africa and South America, whereas Metrifonate has been using to treat urinary schistosomiasis
  • 2. worldwide, artemisisnin is significantly less effective against adult schistosome parasites. Due to lake of proper treatment and preventive therapy the rate of the disease occurrence is increasing rapidly worldwide and will become a remarkable threat to human populations in the near future. The eradication of the disease is completely impossible, as there are no vaccine for the parasitic disease has reported untill now. Under the present circumstances, a safe, non-toxic but effective drug should be urgently introduced to control the schistosomiasis in novel way by targeting common biochemical mechanism. Thioredoxin glutathione reductase (TGR) is one of such common pathway which present in all developmental stages as well as in all infectious pathogen. By quantitative high-throughput screen (qHTS) of NIH Molecular Libraries, followed by confirmatory and target deconvolution assay, four promising series were identified (1. oxadiazole 2-oxides, 2. phosphinic amides, 3. quinolinyl sulfonamides , 4. Phosphoramidite) as Thioredoxin glutathione reductase (TGR) inhibitors. The aim of this study was to analyse the activity phosphinic amides and oxadiazole 2-oxides against antioxidant pathway at all developmental stages of parasite as well as all major species infecting humans, and S. mansoni–infected mice. Among the ten selected compound, 4-phenyl-1,2,5-oxadiazole-3-carbonitrile-2-oxide showed most active against in-vitro adult pathogen as well as multiple parasitic stages and egg- associated pathologies by generating NO. The protective activity of the compound was also observed against the three major species of schistosome pathogen infecting human. The cytotoxic effect of the compound was lower as compared to the PZQ. Discussion: The level of activity of compound 9 was equal to or better than that of the currently used drug, PZQ, and surpasses all landmarks for new lead compounds for schistosomiasis control. The low cytotoxicity and high bioactivity and tolerance by mice of compound 9 support the potential of this compound as a highly effective lead compound for human schistosomiasis. in the series of oxadiazole 2-oxides, 4-phenyl-1,2,5-oxadiazole-3-carbonitrile-2-oxide is identified as the most active compound which showed a significant activity against almost all stages of the parasite life cycle. Therefore it might be a effective drug to treat both short-term and long-term schistosomiasis. Thus, the compound might be potential new drug which able to treat schistosomiasis more effectively at any point during the infection. Unlike PZQ, the compound able to reduce the larval count in lung, it might be a promising prophylactic drug for schistosomiasis treatment. PZQ is much less effective against juvenile liver parasites than against adult parasites, producing only a 25–30% reduction in worm burdens. Although artemether affords B80% reduction if juvenile parasites are targeted, it is less effective against adult schistosome parasites, resulting in o50% reduction in worm burden 31. In addition, compound 9 was found to be active against adults…..
  • 3. compound 9 was found to be active against adults of the other main schistosome species infecting humans, S. japonicum and S. haematobium. Therefore, compound 9, or its derivatives, could be useful…… The almost completely dependence on PZQ for schistosomiasis treatment lead to the increase of developing resistant strains worldwide resulting in out-of-control of the disease effect. A the compound have different mode of action than PZQ to kill the pathogen, might be a potential drug to treat PZQ-resistant strain. Apart from this, the compound might be a perfect choice for combination therapy with PZQ or artemisnin to treat more effectively than alone. Future scope: The analysis is undoubtedly a prominence step forward, but the goal of new schistomatosis drug development is far from the point of view. Rather, it envisages an initiative point to develop new safe but potential drug to control the divesting effect of sichtomatosis worldwide. Although the study conclude that the compound has a less cytotoxic effect with better tolerance by mouse in comparison to currently used drug PZQ, further study needs to confirm the protective activity against all developmental stage of the compound is more than the currently used drug, PZQ. Next goal would be to measure the efficiency of the compound against all developmental stage in a single in vivo experiment by using PZQ as a positive control. The compound act as TGR inhibitor lead to impairment of redox mechanism in pathogen, ultimately kill it. Like PZQ, the killed pathogen in host tissue may be target by the host’s immune system to eliminate by phagosytosis. Thus the efficacy of the drug might also be depending on the host immunity; consequently sex, race or others. However the effect of the compound on the host’s cell-enzyme: Thioredoxin Reductase (TrxR), Glutaredoxin (Grx) and Glutathione Reductase (GR) also needs to analyze. By using various derivatives of the compound, the efficacy of the drug might possible to increase selectively. As the compound generates toxic NO, the side effects also need to analyze more details before using as drug. It is important to conduct pharmacokinetic analysis of the compound for biological half life , excretion or elimination rate constant for the compound before going to clinical trial. Ref:
  • 4. 1. Hotez, P.J. et al. Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018–1027 (2007). 2. Fallon, P.G. & Doenhoff, M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51, 83–88 (1994). 3. Herwaldt, B.L., Tao, L.F., van Pelt, W., Tsang, V.C. & Bruce, J.I. Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin. Infect. Dis. 20, 309–315 (1995). 4. Murray-Smith, S.Q., Scott, B.J., Barton, D.P. & Weinstein, P. A case of refractory schistosomiasis. Med. J. Aust. 165, 458 (1996). 5. Ismail, M. et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60, 932–935 (1999). 6. Simeonov, A. et al. Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Negl. Trop. Dis 2, e127 (2008). 7.